22May 2021
Longitudinal Follow‐up and Performance Validation of a mRNA‐based Urine Test (Xpert® Bladder Cancer Monitor) for surveillance in Non‐Muscle Invasive Bladder Cancer Patients

Longitudinal Follow‐up and Performance Validation of a mRNA‐based Urine Test (Xpert® Bladder Cancer Monitor) for surveillance in Non‐Muscle Invasive Bladder Cancer Patients

Frequent recurrences and the potential for progression of non‐muscle‐invasive bladder cancer (NMIBC) demand close surveillance. This prospective study evaluated the performance of Xpert Bladder Cancer Monitor (Xpert) test as a predictor of tumor recurrence...

  • #urology

Like

Save

Share